The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 01, 2012

Filed:

Sep. 14, 2009
Applicants:

Koichi Shudo, Tokyo, JP;

Hiroyuki Kagechika, Tokyo, JP;

Hiroshi Fukasawa, Tokyo, JP;

Tetsuro Matsuishi, Tokyo, JP;

Naoko Katsumura, Tokyo, JP;

Miwako Ishido, Tokyo, JP;

Inventors:

Koichi Shudo, Tokyo, JP;

Hiroyuki Kagechika, Tokyo, JP;

Hiroshi Fukasawa, Tokyo, JP;

Tetsuro Matsuishi, Tokyo, JP;

Naoko Katsumura, Tokyo, JP;

Miwako Ishido, Tokyo, JP;

Assignee:

Kemphys Ltd., Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/192 (2006.01); A61K 31/554 (2006.01); A61K 31/5513 (2006.01); A61K 31/695 (2006.01);
U.S. Cl.
CPC ...
Abstract

Method for therapeutic treatment of inflammatory bowel disease, including Crohn's disease, comprising administering to a patient in need thereof a therapeutically effective amount of a composition comprising a retinoid as an active ingredient to treat the inflammatory bowel disease, the retinoid being selected from the group consisting of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carbamoyl]benzoic acid, 4-[(3,5-bis-trimethylsilylphenyl)carboxamido]benzoic acid, 4-[2,3-(2,5-dimethyl-2,5-hexano)dibenzo[b,f][1,4]thiazepin-11-yl]benzoic acid, and 4-(5H-7,8,9,10-tetrahydro-5,7,7,10,10-pentamethylbenzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid.


Find Patent Forward Citations

Loading…